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1Association between Smoking and 
Functional Outcome in Acute lschemic 
Stroke Population Treated with Tissue 
Plasminogen Activator 
lretioluwa Ajani , Oluyeml Rotimi, Olubunmi Kuku, Ndukwe Kalu , Olakunle Oni, 
Nwabueze Christian , Thomas Nathaniel and Shimin Zheng 
Department of Biostatistics and Epidemiology, College of Public Health, East 
Tennessee State University , Johnson City, TN 37614 
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Ischemic strokes which happen when the artery that supplies blood to that part of 
the brain gets blocked; this blockage is often due to blood clots.3
3
4Background 
• Tissue Plasminogen Activator (tPA) is a thrombolytic 
agent used to treat ischemic type stroke2 
• Several studies show an association between 
smoking and lower mortality rates2-3 
While it is common knowledge that smoking cigarette increases the risk of having a 
stroke,4 several studies have shown an association between smoking and lower 
mortality rate in patients treated with tPA.5–8 There are theories that explain this 
smoking-thrombolytic paradox based on clot formation. A study on the effects of 
smoking on clot formation found that cigarette smoke exposure changes clot 
dynamics and the fibrin structure.9 It increases the formation of fibrin-rich blood 
clots due to increase platelet activation and higher intra-arterial fibrinogen and fibrin 
concentrations, thus a smokers blood is in a hypercoagulable state.9,10 This makes 
the clots more susceptible to tPA treatments when compare with clots that are 
formed through other means.4,11 Other studies didn’t find such association and 
some even found poorer outcomes in smokers as compared to non-smokers. 12,13
5
Background 
• Barua et al hypothesized that cigarette smoke exposure 
changes clot dynamics and the fibrin structure making 
clot more susceptible tot Pa treatment.3 
• Other studies didn't find such association and some even 
found poorer outcomes in smokers. 
6Background 
• This study seeks to determine the association between 
smoking and functional improvement in stroke cases 
treated with tPA and stroke cases not that did not 
receive tPA treatment. 
Smoking habits were assessed by a stroke neurologist within 24 h after admission. 
Current smoking was defined as smoking at least one cigarette per day. No smoking 
was considered present if the patient had never smoked.
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Statistical 
analysis 
c We compared functional outcome and 
predictor variable using Univariate analyses. 
:) Fisher's exact test and Pearson 's chi-square 
test were used for categorical variables. 
c Logistic regression analyses were performed 
with favorable outcome (mRS 0-1) vs 
unfavorable outcome (mRS 2- 6) as 
dependent variable . 
C) Variables from the univariate analysis were 
included in the fina l model based on a cut 
point p-value of 0.2 and an absence of multi 
collinearity. 
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RESULT 
Table 1. Characteristics of smoking and non-smoking stroke patients treated with tPA or stroke patients 
admitted within 6 h after stroke onset not treated with tPA 
tPA no tPA 
Smoking status Smokers Non-smokers P-value Smokers Non-smokers P-value 
No of patients 181 414 198 653 
Age Group(Mean ± SD) 56.69 ± 12.25 69.60 ± 14.36 < 0.0001 • 59.52 ± 11.84 73.15 ± 14.05 < 0.0001 • 
Race: No. (%) 0.0408* 0.0055• 
Caucasian 136 (75.14) 345 (83.33) 147 (74.24) 529 (81.01) 
African-American 44 (24.31) 65 (15.70) 51 (25.76) 112 (17.15) 
Other 1 (0.55) 4 (0.97) 0 (0.00) 12 (l.84)bh 
Gender: No. (%) 0.0083* < 0.0001 • 
Male 110 (60.77) 203 (49.03) 123 (62.12) 276 (42.27) 
Female 71 (39.23) 211 (50.97) 75 (37.88) 377 (57.73) 
Body Mass Index (Mean± SD) 28.11 ± 6.60 29.14 ± 6.70 27.98 ± 8.51 28.34 ± 7.14 
MRS 0.0097* 0.0045* 
Favorable Outcome 124 (68.51) 237 (57.25) 107 (54.04) 278 (42.57) 
Unfavorable Outcome 57 (31.49) 177 (42.75) 91 (45.96) 375 (57.43) 
Risk of MortalityGWTG lschemic Stroke (Mean± 
SD) 4.46 ± 4.41 6.11 ± 6.2 3.66 ± 3.92 5.39 ± 5.91 
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Table 2: Multiple Logistic regression analysis with mRS 0-1 or 2-6 as 
dependent variable among stroke patients treated with tPA 
Adjusted Odds 
AUC = 72.18 Ratio 95%(1 p 
Smoking 0.887 0.569- 1.383 0.596 
Age 0.954 0.940- 0.969 <.0001 
Sex {M vs F?) 0.767 0.533- 1.105 0.155 
NIH scale 0.938 0.912- 0.965 <.0001 
BMI 1.008 0.979- 1.037 0.5943 
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Table3. Multiple Logistic regression analysis with mRS 0-1 or 2-6 as dependent 
variable among stroke patients treated without tPA 
Adjusted Odds 
AUC =73.34 Ratio 95%(1 p 
Smoking 0.956 0.655- 1.395 0.8164 
Age 0.966 0.955- 0.978 <.0001 
Sex 0.723 0.535- 0.977 0.0349 
NIH scale 0.906 0.884- 0.928 <.0001 
BMI 1.017 0.995- 1.039 0.1403 
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Of 1,446 patients, 595 (41.15 %) were treated with TPA (181 smokers (47.76 %), 414 
non-smokers (52.24 %) and 851 (58.85%) not treated with TPA (198 smokers (38.8 %), 
653 non-smokers (61.2 %). In the multivariable models, smoking was not 
independently associated with favorable outcome in patients treated with TPA (OR = 
0.84; 95% CI = 0.54 – 1.33; P-value = 0.46) and those not treated with TPA (OR = 0.96; 
95% CI = 0.64 – 1.44; P-value = 0.85) though the bivariate models showed significant 
association.
Conclusion
There is no association between smoking and functional outcome in stroke patients 
regardless of TPA treatment. The effect of smoking on outcome in acute ischemic 
stroke patients treated with tissue plasminogen activator (TPA) is however stronger 
than those not treated with TPA.
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